Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers

被引：53

作者：

Huffman, Brandon M. ^{[1
]}

Aushev, Vasily N. ^{[2
]}

Budde, Griffin L. ^{[2
]}

Chao, Joseph ^{[3
]}

Dayyani, Farshid ^{[4
]}

Hanna, Diana ^{[5
]}

Botta, Gregory P. ^{[6
]}

Catenacci, Daniel V. T. ^{[7
]}

Maron, Steven B. ^{[8
]}

Krinshpun, Shifra ^{[2
]}

Sharma, Shruti ^{[2
]}

George, Giby V. ^{[2
]}

Malhotra, Meenakshi ^{[2
]}

Jurdi, Adham ^{[2
]}

Moshkevich, Solomon ^{[2
]}

Aleshin, Alexey ^{[2
]}

Kasi, Pashtoon M. ^{[9
]}

Klempner, Samuel J. ^{[1
]}

机构：

[1] Massachusetts Gen Hosp, Dept Med, Div Hematol Oncol, Ctr Canc, Boston, MA 02114 USA

[2] Natera Inc, Austin, TX USA

[3] City Hope Comprehens Canc Ctr, Duarte, CA USA

[4] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA

[5] USC, Keck Hosp, Los Angeles, CA USA

[6] UCSD Moores Canc Ctr, La Jolla, CA USA

[7] Univ Chicago, Chicago, IL 60637 USA

[8] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[9] New York Presbyterian Hosp, Englander Inst Precis Med, Weill Cornell Med, New York, NY USA

来源：

JCO PRECISION ONCOLOGY | 2022年 / 6卷

关键词：

GASTROESOPHAGEAL JUNCTION; RESIDUAL DISEASE; OPEN-LABEL; SURGERY; CHEMORADIOTHERAPY; MICROMETASTASIS; CHEMORADIATION; CHEMOTHERAPY; CAPECITABINE; OXALIPLATIN;

D O I：

10.1200/PO.22.00420

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PURPOSE Circulating tumor DNA (ctDNA) analyses allow for postoperative risk stratification in patients with curatively treated colon and breast cancers. Use of ctDNA in esophagogastric cancers (EGC) is less characterized and could identify high-risk patients who have been treated with curative intent. METHODS In this retrospective analysis of real-world data, ctDNA levels were analyzed in the preoperative, postoperative, and surveillance settings in patients with EGC using a personalized multiplex polymerase chain reaction-based next-generation sequencing assay. Plasma samples (n = 943) from 295 patients at. 70 institutions were collected before surgery, postoperatively, and/or serially during routine clinical follow-up from September 19, 2019, to February 21, 2022. ctDNA detection was annotated to clinicopathologic features and recurrence-free survival. RESULTS A total of 295 patients with EGC were analyzed, and 212 patients with stages I-III disease were further explored. Pretreatment ctDNA was detected in 96% (23/24) of patients with preoperative time points. Postoperative ctDNA was detected in 23.5% (16/68) of patients with stage I-III EGC within 16 weeks (molecular residual disease window) after surgery without receiving systemic therapy. ctDNA detection at any time point after surgery (hazard ratio [HR], 23.6; 95% CI, 10.2 to 66.0; P<.0001), within the molecular residual disease window (HR, 10.7; 95% CI, 4.3 to 29.3; P<.0001), and during the surveillance period (HR, 17.7; 95% CI, 7.3 to 50.7; P<.0001) was associated with shorter recurrence-free survival. In multivariable analysis, ctDNA status and clinical stage of disease were independently associated with outcomes. CONCLUSION Using real-world data, we demonstrate that postoperative tumor-informed ctDNA detection in EGC is feasible and allows for enhanced patient risk stratification and prognostication during curative-intent therapy. (c) 2022 by American Society of Clinical Oncology

引用

页数：15

共 34 条

[1] Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial [J].

Al-Batran, Salah-Eddin ;

Homann, Nils ;

Pauligk, Claudia ;

Goetze, Thorsten O. ;

Meiler, Johannes ;

Kasper, Stefan ;

Kopp, Hans-Georg ;

Mayer, Frank ;

Haag, Georg Martin ;

Luley, Kim ;

Lindig, Udo ;

Schmiegel, Wolff ;

Pohl, Michael ;

Stoehlmacher, Jan ;

Folprecht, Gunnar ;

Probst, Stephan ;

Prasnikar, Nicole ;

Fischbach, Wolfgang ;

Mahlberg, Rolf ;

Trojan, Joerg ;

Koenigsmann, Michael ;

Martens, Uwe M. ;

Thuss-Patience, Peter ;

Egger, Matthias ;

Block, Andreas ;

Heinemann, Volker ;

Illerhaus, Gerald ;

Moehler, Markus ;

Schenk, Michael ;

Kullmann, Frank ;

Behringer, Dirk M. ;

Heike, Michael ;

Pink, Daniel ;

Teschendorf, Christian ;

Loehr, Carmen ;

Bernhard, Helga ;

Schuch, Gunter ;

Rethwisch, Volker ;

von Weikersthal, Ludwig Fischer ;

Hartmann, Joerg T. ;

Kneba, Michael ;

Daum, Severin ;

Schulmann, Karsten ;

Weniger, Joerg ;

Belle, Sebastian ;

Gaiser, Timo ;

Oduncu, Fuat S. ;

Guentner, Martina ;

Hozaeel, Wael ;

Reichart, Alexander .

LANCET, 2019, 393 (10184) :1948-1957

[2] Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial [J].

Al-Batran, Salah-Eddin ;

Hofheinz, Ralf D. ;

Pauligk, Claudia ;

Kopp, Hans-Georg ;

Haag, Georg Martin ;

Luley, Kim Barbara ;

Meiler, Johannes ;

Homann, Nils ;

Lorenzen, Sylvie ;

Schmalenberg, Harald ;

Probst, Stephan ;

Koenigsmann, Michael ;

Egger, Matthias ;

Prasnikar, Nicole ;

Caca, Karel ;

Trojan, Joerg ;

Martens, Uwe M. ;

Block, Andreas ;

Fischbach, Wolfgang ;

Mahlberg, Rolf ;

Clemens, Michael ;

Illerhaus, Gerald ;

Zirlik, Katja ;

Behringer, Dirk M. ;

Schmiegel, Wolff ;

Pohl, Michael ;

Heike, Michael ;

Ronellenfitsch, Ulrich ;

Schuler, Martin ;

Bechstein, Wolf O. ;

Koenigsrainer, Alfred ;

Gaiser, Timo ;

Schirmacher, Peter ;

Hozaeel, Wael ;

Reichart, Alexander ;

Goetze, Thorsten O. ;

Sievert, Mark ;

Jaeger, Elke ;

Moenig, Stefan ;

Tannapfel, Andrea .

LANCET ONCOLOGY, 2016, 17 (12) :1697-1708

[3]

Bang YJ, 2010, LANCET, V376, P1302

[4] Limited Sensitivity of Circulating Tumor DNA Detection by Droplet Digital PCR in Non-Metastatic Operable Gastric Cancer Patients [J].

Cabel, Luc ;

Decraene, Charles ;

Bieche, Ivan ;

Pierga, Jean-Yves ;

Bennamoun, Mostefa ;

Fuks, David ;

Ferraz, Jean-Marc ;

Lefevre, Marine ;

Baulande, Sylvain ;

Bernard, Virginie ;

Vacher, Sophie ;

Mariani, Pascale ;

Proudhon, Charlotte ;

Bidard, Francois-Clement ;

Louvet, Christophe .

CANCERS, 2019, 11 (03)

[5] Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence [J].

Coombes, Raoul Charles ;

Page, Karen ;

Salari, Raheleh ;

Hastings, Robert K. ;

Armstrong, Anne ;

Ahmed, Samreen ;

Ali, Simak ;

Cleator, Susan ;

Kenny, Laura ;

Stebbing, Justin ;

Rutherford, Mark ;

Sethi, Himanshu ;

Boydell, Anna ;

Swenerton, Ryan ;

Fernandez-Garcia, Daniel ;

Gleason, Kelly L. T. ;

Goddard, Katie ;

Guttery, David S. ;

Assaf, Zoe J. ;

Wu, Hsin-Ta ;

Natarajan, Prashanthi ;

Moore, David A. ;

Primrose, Lindsay ;

Dashner, Scott ;

Tin, Antony S. ;

Balcioglu, Mustafa ;

Srinivasan, Ramya ;

Shchegrova, Svetlana V. ;

Olson, Alexander ;

Hafez, Dina ;

Billings, Paul ;

Aleshin, Alexey ;

Rehman, Farah ;

Toghill, Bradley J. ;

Hills, Allison ;

Louie, Maggie C. ;

Lin, Cheng-Ho Jimmy ;

Zimmermann, Bernhard G. ;

Shaw, Jaqueline A. .

CLINICAL CANCER RESEARCH, 2019, 25 (14) :4255-4263

[6] Capecitabine and oxaliplatin for advanced esophagogastric cancer [J].

Cunningham, David ;

Starling, Naureen ;

Rao, Sheela ;

Iveson, Timothy ;

Nicolson, Marianne ;

Coxon, Fareeda ;

Middleton, Gary ;

Daniel, Francis ;

Oates, Jacqueline ;

Norman, Andrew Richard .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (01) :36-46

[7] Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer in the per-protocol analysis of the randomized CRITICS trial [J].

de Steur, W. O. ;

van Amelsfoort, R. M. ;

Hartgrink, H. H. ;

Putter, H. ;

Kranenbarg, E. Meershoek-Klein ;

van Grieken, N. C. T. ;

van Sandick, J. W. ;

Claassen, Y. H. M. ;

Braak, J. P. B. M. ;

Jansen, E. P. M. ;

Sikorska, K. ;

van Tinteren, H. ;

Walraven, I ;

Lind, P. ;

Nordsmark, M. ;

Henegouwen, M. I. van Berge ;

van Laarhoven, H. W. M. ;

Cats, A. ;

Verheij, M. ;

van de Velde, C. J. H. .

ANNALS OF ONCOLOGY, 2021, 32 (03) :360-367

[8] Detection of Circulating Tumor DNA in Plasma: A Potential Biomarker for Esophageal Adenocarcinoma [J].

Egyud, Matthew ;

Tejani, Mohamedtaki ;

Pennathur, Arjun ;

Luketich, James ;

Sridhar, Praveen ;

Yamada, Emiko ;

Stahlberg, Anders ;

Filges, Stefan ;

Krzyzanowski, Paul ;

Jackson, Jennifer ;

Kalatskaya, Irina ;

Jiao, Wei ;

Nielsen, Gradon ;

Zhou, Zhongren ;

Litle, Virginia ;

Stein, Lincoln ;

Godfrey, Tony .

ANNALS OF THORACIC SURGERY, 2019, 108 (02) :343-349

[9] Assessment of Molecular Remission in Oligometastatic Esophageal Cancer With a Personalized Circulating Tumor DNA Assay [J].

Einstein, David J. ;

Liang, Nathan ;

Malhotra, Meenakshi ;

Aleshin, Alexey ;

Moshkevich, Solomon ;

Billings, Paul R. ;

Pectasides, Eirini .

JCO PRECISION ONCOLOGY, 2020, 4 :239-243

[10] Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial [J].

Eyck, Ben M. ;

van Lanschot, J. Jan B. ;

Hulshof, Maarten C. C. M. ;

van der Wilk, Berend J. ;

Shapiro, Joel ;

van Hagen, Pieter ;

Henegouwen, Mark I. van Berge ;

Wijnhoven, Bas P. L. ;

van Laarhoven, Hanneke W. M. ;

Nieuwenhuijzen, Grard A. P. ;

Hospers, Geke A. P. ;

Bonenkamp, Johannes J. ;

Cuesta, Miguel A. ;

Blaisse, Reinoud J. B. ;

Busch, Olivier R. ;

Creemers, Geert-Jan M. ;

Punt, Cornelis J. A. ;

Plukker, John Th M. ;

Verheul, Henk M. W. ;

Bilgen, Ernst J. Spillenaar ;

van der Sangen, Maurice J. C. ;

Rozema, Tom ;

Ten Kate, Fiebo J. W. ;

Beukema, Jannet C. ;

Piet, Anna H. M. ;

van Rij, Caroline M. ;

Reinders, Janny G. ;

Tilanus, Hugo W. ;

Steyerberg, Ewout W. ;

van der Gaast, Ate .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (18) :1995-+

← 1 2 3 4 →